Evaluation of Coleman Lipostructure for Treatment of Facial Lipoatrophy in Patients With Human Immunodeficiency Virus and Parameters Associated With the Efficiency of This Technique

Abstract

Our 1-year evaluation of Coleman lipostructure for correction of facial lipoatrophy in HIV-infected patients proved the efficiency of this treatment when measured conservatively by agreement on improvement by 3 independent specialists and demonstrated a patient satisfaction rate of 93%.

References

Page 1

	Year	Citations
1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults K. G. Castro, Jill Ward, Laurence Slutsker, Clinical Infectious Diseases ImmunodeficienciesHiv/aids CounsellingAdolescent MedicineHuman RetrovirusClinical Epidemiology	1993	4.4K
Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study Andrew Carr, Katherine Samaras, Gilbert R. Kaufmann, The Lancet ObesityMetabolic SyndromeCardiovascular DiseaseHiv-1 Protease-inhibitor-associated LipodystrophyAcohort Study	1999	1.5K
Facial Recontouring with Lipostructure Sydney R. Coleman Clinics in Plastic Surgery Gross AnatomyFacial PlasticAesthetic SurgeryFacial ReconstructionCleft Lip Repair	1997	1K
Long-Term Survival of Fat Transplants: Controlled Demonstrations Sydney R. Coleman Aesthetic Plastic Surgery ObesityFat TransplantsBody CompositionGraft Survival	2020	699
Structural fat grafts: the ideal filler? Stephen Coleman PubMed	2001	602
Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study Estebán Martínez, Amanda Mocroft, Miguel A García-Viejo, The Lancet Protease InhibitorsHiv-1-infected PatientsEpidemiologyTreatment And PreventionClinical Epidemiology	2001	457
Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance Jean-Philippe Bastard, Martine Caron, Hubert Vidal, The Lancet Insulin ResistanceMetabolic SyndromeMetabolic DisorderPhysiologyImmunology	2002	408
Polylactic acid implants (New-Fill)® to correct facial lipoatrophy in HIV-infected patients Marc‐Antoine Valantin, Camille Aubron‐Olivier, Jade Ghosn, AIDS	2003	360
Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy Pere Domingo, Xavier Matías‐Guiu, Ramón M. Pujol, AIDS	1999	239
Psychosocial impact of the lipodystrophy syndrome in HIV infection. E.J. Collins, C Wagner, Sharon Walmsley PubMed ObesitySexual HealthAntiretroviral TherapyBody CompositionCentral Fat Accumulation	2000	192

Page 1